Search results
Allucent Receives BARDA-Funded Project NextGen Award to Support a COVID-19 Vaccine Decentralized...
WKBN 27 Youngstown· 17 hours agoAuthority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS). Funding for this award was received under ...
Being vaccinated against COVID-19 reduces the severity of the illness
Digital Journal· 7 days agoA new study reveals how COVID-19 vaccines prevent severe disease. This is based on research...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize ...
Benzinga· 6 days agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID ...
Expert reaction: AstraZeneca withdraws its COVID-19 vaccine
Cosmos· 5 days agoAstraZeneca developed the first vaccine for COVID-19, beating the competition, but this week they’ve...
The Silence Around Covid Vaccine Injuries
The Intercept· 3 days agoThis week on Deconstructed, Wightman shares his story with Ryan Grim. Days after receiving an AstraZeneca Covid-19 vaccine in 2021, Wightman ...
Opinion | Now is the time to talk about vaccines, but Covid-19 leaves polarising legacy
South China Morning Post· 2 days agoIn the US, drug makers were given immunity from lawsuits under agreements with the government, which...
Earnings call: GeoVax reports progress on key vaccine trials By Investing.com
Investing.com· 19 hours agoCEO David Dodd discussed significant advancements in the company's Phase 2 clinical trials,...
...Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop...
CBS 47 Fresno· 6 days ago-M™ adjuvant, has entered into a co-exclusive licensing agreement with Sanofi (Nasdaq: SNY). The terms of the agreement include: a co-exclusive license to co-commercialize Novavax's current ...
Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines
Investopedia· 6 days agoSanofi agreed to pay Novavax $500 million upfront, with another $700 million in possible payments...
What to know about the COVID-19 FLiRT variant as it spreads in Connecticut ahead of summer
The News-Times· 1 day agoA new group of COVID-19 variants called “FLiRT” are rapidly becoming the dominant mutations of the...